Table 1.
Role of IFN-α, IFN-β, and IFN-γ in pain and the underlying mechanisms.
IFNs | Doses | Routes | Species | Conditions | Actions | Mechanisms | References |
---|---|---|---|---|---|---|---|
IFN-α | 500 U | Intracerebral | Mouse | Naïve | Antinociception | Opioid receptor dependent | 32 |
4, 8, 16 pmole | Intracranial ventricle | Rat | Naïve | Antinociception | μ-opioid receptor dependent | 33 | |
100 ng | Intrathecal | Rat | Naïve, CFA | Antinociception | Opioid receptor dependent | 9 | |
100 ng | Intrathecal | Rat | Naïve, CFA | Antinociception | Inhibits EPSC and capsaicin-induced P-ERK | 34 | |
300 U | Intraplantar | Mouse | Naïve | Hyperalgesia | Activation of MAPK and MNK-eIF4e translation | 35 | |
100 U | Intrathecal | Mouse | Naïve | Antinociception | IFNAR-1 mediated actions; inhibition of Nav 1.7 and calcium channel activities | 11 | |
IFN-β | 100 ng | Intrathecal | Mouse | LPS | Antinociception | IFNAR-1 mediated and TLR-mediated actions | 36 |
3600 U | Intrathecal | Mouse | Arhtritis | Co-injection with TNF antibody produces long-term pain relief | Induction of IL-10 expression | 37 | |
1000, 5000, 10000 U | Intrathecal | Mouse | Spared nerve injury | Antinociception | Induction of ISG-15 and inhibition of MAPK | 38 | |
300 U | Intraplantar | Mouse | Naïve | Hyperalgesia | Activation of MAPK and MNK-eIF4e translation | 35 | |
100 U | Intrathecal | Mouse | Naïve | Antinociception | IFNAR-mediated actions; inhibition of Nav 1.7 and calcium channel activities | 8 | |
IFN-γ | 20000 U/mL | Incubation 14d | Rat | Dorsal horn neuron | Increase EPSC | decrease inhibitory neuron GluR 1 | 39 |
1000U | Intrathecal | Rat | Naïve | Hyperalgesia | Activation of IFN-γ receptor in Microglia | 7 | |
1000U | Spinal dorsal nerve | Rat | Naïve | Hyperalgesia | Increase C-fiber response | 40 | |
1000U | Intrathecal | Rat | Naïve | Hyperalgesia | Activation of astrocyte | 41 | |
2000 U/mL | Incubation 4-8h | Rat | Spinal cord slice | Increase C-fiber EPSC | Activation of Microglia | 42 |